Scarica l'app Stockscreener
4.53
1.12%
0.05
Dopo l'orario di chiusura:
4.53
Precedente Chiudi:
$4.48
Aprire:
$4.38
Volume 24 ore:
436.52K
Relative Volume:
0.54
Capitalizzazione di mercato:
$582.33M
Reddito:
$201.49M
Utile/perdita netta:
$-66.54M
Rapporto P/E:
-8.7166
EPS:
-0.5197
Flusso di cassa netto:
$-8.88M
1 W Prestazione:
-1.09%
1M Prestazione:
+2.26%
6M Prestazione:
+24.11%
1 anno Prestazione:
+13.53%
Intervallo 1D:
$4.34
$4.65
Intervallo di 1 settimana:
$4.19
$4.65
Portata 52W:
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.53 | 582.33M | 201.49M | -66.54M | -8.88M | -0.5197 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - sahmcapital.com
EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - finance.yahoo.com
Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan
Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan
Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan
Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan
Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Weekly Voice
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - MarketBeat
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail
Cytek Biosciences, Inc. (CTKB) Presents at TD Cowen 46th Annual Health Care ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Increases Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.50 Average PT from Brokerages - Defense World
CTKB SEC FilingsCytek Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights By Investing.com - Investing.com Canada
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights - Investing.com India
Buyback Watch: What is the Moat Score of Cytek Biosciences IncStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
CTKB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cytek Biosciences outlines cell sorting breakthroughs in webinar - Traders Union
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytek (CTKB) Q4 2025 Earnings Call Transcript - AOL.com
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Earnings call transcript: Cytek Biosciences Q4 2025 sees record revenue, EPS miss - Investing.com South Africa
Cytek Biosciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cytek Biosciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CTKB) 2026-02-27 - Seeking Alpha
Cytek Biosciences earnings missed by $0.32, revenue topped estimates - Investing.com Canada
Cytek Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings Call Summary | Cytek Biosciences(CTKB.US) Q4 2025 Earnings Conference - 富途牛牛
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings - ChartMill
Cytek Biosciences Inc. (CTKB) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Cytek Biosciences (CTKB) swings to deeper 2025 loss with soft 2026 growth outlook - Stock Titan
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):